| Q35818217 | A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane |
| Q41140320 | A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction). |
| Q53537715 | Accelerated healing in NONcNZO10/LtJ type 2 diabetic mice by FGF-1. |
| Q42824584 | Acidic fibroblast growth factor accelerates dermal wound healing |
| Q36530293 | Acidic fibroblast growth factor in the developing rat embryo |
| Q33850198 | Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix |
| Q37600499 | Acidic fibroblast growth factor promotes vascular repair |
| Q28567368 | Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor |
| Q41341047 | An angiogenic growth factor is expressed in human glioma cells. |
| Q40400185 | Angiogenesis: models and modulators. |
| Q34101582 | Angiogenin-mediated ribosomal RNA transcription as a molecular target for treatment of head and neck squamous cell carcinoma |
| Q41751468 | Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium |
| Q37401185 | Basic fibroblast growth factor induces angiogenesis in vitro |
| Q42861894 | Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures |
| Q24302929 | Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors |
| Q24634413 | Cloning of the gene coding for human class 1 heparin-binding growth factor and its expression in fetal tissues |
| Q43201136 | Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro |
| Q28570754 | Copper chelation represses the vascular response to injury |
| Q36426318 | Crystallization and preliminary X-ray analysis of human S100A13. |
| Q44333243 | Culture of human corpus cavernosum endothelium |
| Q38313935 | Densimetric determination of equilibrium binding of sucrose octasulfate with basic fibroblast growth factor |
| Q35608426 | Developing brain produces an angiogenesis factor |
| Q68488485 | Differential expression of mRNA coding for heparin-binding growth factor type 2 in human cells |
| Q41757013 | Disulfide Bonds are Neither Required, Present, Nor Compatible with Full Activity of Human Recombinant Acidic Fibroblast Growth Factor |
| Q42249378 | Dramatic resolution of vitreous hemorrhage after an intravitreal injection of dobesilate |
| Q37314844 | Durable recovery of the macular architecture and functionality of a diagnosed age-related macular degeneration 1 year after a single intravitreal injection of dobesilate |
| Q42465245 | Effect of inflammatory cytokines on human endothelial cell proliferation |
| Q34553837 | Effects of endothelial cell growth factor on bone remodelling in vitro |
| Q44471371 | Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells |
| Q41091747 | Expression of acidic fibroblast growth factor cDNA confers growth advantage and tumorigenesis to Swiss 3T3 cells |
| Q35832753 | Expression of growth factor and receptor mRNAs in skin epithelial cells following acute cutaneous injury |
| Q42646266 | Expression of vascular endothelial growth factor in oral squamous cell carcinoma |
| Q24561476 | FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern |
| Q35279852 | Factors controlling pancreatic islet neogenesis. |
| Q44288567 | Fibroblast growth factor induces the soft agar growth of two non-transformed cell lines |
| Q42831606 | Fibroblast variants nonresponsive to fibroblast growth factor 1 are defective in its nuclear translocation |
| Q24298832 | Gentisic acid, a compound associated with plant defense and a metabolite of aspirin, heads a new class of in vivo fibroblast growth factor inhibitors |
| Q45081025 | Glioma-stimulated chemoattraction of endothelial cells and fibroblasts in vitro: a model for the study of glioma-induced angiogenesis |
| Q55485758 | Glomeruloid blood vessels in ethylnitrosourea-induced rat gliomas. Histological and immunohistochemical studies. |
| Q71678765 | Glycosaminoglycans enhance phorbol ester-induced proteolytic activity and angiogenesis in vitro |
| Q40418085 | Growth factors in the CNS and their effects on oligodendroglia |
| Q36776434 | Heparin-binding growth factor 1 stimulates tyrosine phosphorylation in NIH 3T3 cells |
| Q42805228 | Heparin-binding growth factor isolated from human prostatic extracts |
| Q42833313 | Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression |
| Q69400185 | High-performance liquid chromatography of amino acids, peptides and proteins. LXXIV. Separation of heparin-binding growth factors by reversed-phase high-performance liquid chromatography |
| Q69473472 | High-performance liquid chromatography of phenylthiocarbamyl-amino acids. Application to carboxyl-terminal sequencing of proteins |
| Q41100541 | How tumors become angiogenic |
| Q24630121 | Human fibroblast growth factor 1 gene expression in vascular smooth muscle cells is modulated via an alternate promoter in response to serum and phorbol ester |
| Q35599351 | Human tumor cells synthesize an endothelial cell growth factor that is structurally related to basic fibroblast growth factor |
| Q24634292 | Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor) |
| Q57669755 | Immunohistochemical distribution of basic fibroblast growth factor in experimental retinal ischaemia and reperfusion in the rat |
| Q67694731 | Indirect angiogenic agents do not release fibroblast growth factors from extracellular matrix |
| Q36216329 | Inhibition of endothelial cell proliferation by gamma-interferon |
| Q34337298 | Inhibitory action of transforming growth factor beta on endothelial cells |
| Q37365521 | Interleukin 1 regulates heparin-binding growth factor 2 gene expression in vascular smooth muscle cells |
| Q35809793 | Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids |
| Q38198967 | Interleukin-1 and its biologically related cytokines |
| Q41126859 | Intrinsic mitogenic potential of canine flexor tendons |
| Q34242525 | Isolation, characterization, and localization of heparin-binding growth factors in the heart |
| Q69890531 | Kaposi's sarcoma: a reversible hyperplasia |
| Q59074915 | Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α |
| Q70201147 | Malignant tumor cell lines produce interleukin-1-like factor |
| Q36219208 | Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells |
| Q36987868 | Mitogenic regulation of normal and malignant breast epithelium |
| Q50423780 | Molecular Regulation of Sprouting Angiogenesis. |
| Q58551472 | Molecular interactions in juvenile nasopharyngeal angiofibroma: preliminary signature and relevant review |
| Q70321915 | Multiple biological properties of recombinant human interleukin 1 (beta) |
| Q36435897 | Paracrinicity: the story of 30 years of cellular pituitary crosstalk |
| Q34761000 | Peripheral nerve regeneration is impeded by interleukin-1 receptor antagonist released from a polymeric guidance channel |
| Q41508206 | Production of a heparin-binding angiogenesis factor by the embryonic kidney |
| Q68001849 | Production of growth factors related to fibroblast growth factor and platelet-derived growth factor by human embryonal carcinoma cells |
| Q28574927 | Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer |
| Q41858670 | Purification and refolding of vascular endothelial growth factor-B. |
| Q36900227 | Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration |
| Q35597273 | Purification of a factor from human placenta that stimulates capillary endothelial cell protease production, DNA synthesis, and migration. |
| Q37694752 | Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line |
| Q34318542 | Receptor for acidic fibroblast growth factor is related to the tyrosine kinase encoded by the fms-like gene (FLG). |
| Q59067674 | Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo |
| Q69427557 | Response of microvascular endothelial cells to biological response modifiers |
| Q34170878 | Reversible thermal denaturation of human FGF-1 induced by low concentrations of guanidine hydrochloride |
| Q28280225 | S100A13 is involved in the regulation of fibroblast growth factor-1 and p40 synaptotagmin-1 release in vitro |
| Q24301821 | S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells |
| Q42827961 | S100A13 participates in the release of fibroblast growth factor 1 in response to heat shock in vitro |
| Q55919452 | Structural and Functional Diversity in the FGf Receptor Multigene Family |
| Q27649813 | Structure of calcium-bound human S100A13 at pH 7.5 at 1.8 Å resolution |
| Q34467171 | The Fibroblast Growth Factor signaling pathway |
| Q38315715 | The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue |
| Q42835010 | The alternative translation of synaptotagmin 1 mediates the non-classical release of FGF1 |
| Q74243165 | The effect of endothelial cell growth factor on peripheral nerve regeneration |
| Q24297432 | The human FGF-5 oncogene encodes a novel protein related to fibroblast growth factors |
| Q42826176 | The importance of Arg40 and 45 in the mitogenic activity and structural stability of basic fibroblast growth factor: effects of acidic amino acid substitutions. |
| Q36433012 | The influence of heparin on the wound healing response to collagen implants in vivo. |
| Q42833929 | The precursor but not the mature form of IL1alpha blocks the release of FGF1 in response to heat shock |
| Q36958535 | The vascular endothelial growth factor family of polypeptides |
| Q92281605 | Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition) |
| Q67793092 | Transcriptional regulation of basic fibroblast growth factor gene expression in capillary endothelial cells |
| Q40606994 | Transfected MCF-7 cells as a model for breast-cancer progression |
| Q35979853 | Treatment of Stargardt disease with dobesilate |
| Q34932327 | VEGF and the quest for tumour angiogenesis factors |
| Q28201021 | Vascular endothelial growth factor (VEGF) expression in the subacromial bursa is increased in patients with impingement syndrome |
| Q57005503 | Vascular endothelial growth factor messenger ribonucleic acid expression in human ovarian and endometrial cancer |
| Q74237128 | [Demonstration of the angiogenic cytokine vascular endothelial growth factor (VEGF) by non radioactive in situ hybridization] |
| Q46332888 | bFGF is the putative natural growth factor for human melanocytes |